Maxion Therapeutics Secures £58m in Series A Funding
Deal News | Mar 21, 2025 | UK Tech Funding
This article covers a roundup of UK tech funding for the week ending March 21, highlighting several significant investments in the technology sector. Notably, Maxion Therapeutics, a Cambridge-based developer of treatments for inflammatory diseases, received £58 million in a Series A funding round, led by investors including General Catalyst and British Patient Capital. Eventum Orthopaedics, based in Leeds and specializing in surgical devices, secured funding in an Early VC round from Mercia Asset Management. Altogether, five major funding rounds reached a total of £67 million, marking a 9% decrease from the previous week.
Sectors
- Health Tech
- Venture Capital
Geography
- United Kingdom – This is the focal geography as it discusses UK-based companies receiving funding.
Industry
- Health Tech – Involves companies like Maxion Therapeutics and Eventum Orthopaedics, which focus on medical innovations and devices.
- Venture Capital – Includes investment firms like General Catalyst and British Patient Capital, who provide funding for tech startups.
Financials
- £58m – The amount raised by Maxion Therapeutics in a Series A funding round.
- £3m – The amount mentioned in the article attributed to EDX Medical in the health tech sector.
- £67m – The total tracked UK tech investment for the week.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Maxion Therapeutics | Target | Company | A developer of treatments for inflammatory diseases based in Cambridge. |
| Eventum Orthopaedics | Target | Company | A Leeds-based surgical device company that developed the QuadSense device. |
| General Catalyst | Investor | Company | A venture capital firm that participated in the Series A funding round for Maxion Therapeutics. |
| British Patient Capital | Investor | Company | Part of British Business Bank which invests in growing UK companies, participating in Maxion Therapeutics' funding. |
| Solasta Ventures | Investor | Company | A venture capital firm that invested in Maxion Therapeutics. |
| Eli Lilly and Company | Investor | Company | A pharmaceutical company that participated in the Series A funding for Maxion Therapeutics. |
| Mercia Asset Management | Investor | Company | A UK-based asset management firm investing in Eventum Orthopaedics during their Early VC round. |